![]() |
![]() |
triReduce key benefits
minimize capital, costs and risk |
Manage counterparty credit risk
Managing counterparty credit exposure changes through triReduce opens up credit line capacity for new business. Multilateral termination removes transactions and reduces collateral requirements by keeping portfolios trimmed down.
Reduce capital charges
Participating in triReduce cycles reduces both the regulatory and economic capital costs associated with OTC derivatives, especially for capital intensive emerging market transactions.
Eliminate risk-weighted assets from the corporate balance sheet
Periodic compression will eliminate capital charges for risk-weighted assets appearing on the balance sheet. With fewer outstanding OTC derivative trades, a firm can manage its current exposures more effectively by reducing collateral management costs and minimizing balance sheet growth. Compression will also facilitate managing potential future exposure for transactions that can not be collateralized.
|
time New York office +1 646 744 0400 |
time London office +44 20 7382 2200 |
time Stockholm office +46 8 545 25 130 |
time Singapore office +65 6372 8181 |
![]() |
|
|
Disclaimer
Interest Rate Trade Reporting Repository Terms and Conditions for Access and Use
1. Scope of Agreement
2. Intellectual property rights, license to use
3. Prohibited use of Reports
4. Non-reliance, no warranty, disclaimer
Without prejudice to the above, TriOptima shall not be liable to you, or anyone claiming under or through you, for loss of profit, or any indirect or consequential loss or damages under or in connection with this Agreement, the use of any Report or this website, including without limitation, damages for loss of capital, interest, revenue, data or use, or interruption of business, even if you had been advised of the possibility of such damages.
5. Viruses, malware
6. Applicable law, disputes
I agree I decline
|